Skip to main content
Skip to main content
RPNRF logo

Rapid Nutrition PLC (RPNRF) Stock Analysis

DELISTED 2026

What happened to Rapid Nutrition PLC (RPNRF) stock?

Rapid Nutrition PLC (RPNRF) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.

MCap: $4.75M| Vol: 52.7K| 52-wk range: $0.01 – $10000.00
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Rapid Nutrition PLC (RPNRF) trades at $10.00. Rapid Nutrition PLC researches, develops, and produces science-based health and wellness products. Market cap: $4.75M, Sector: Healthcare.

Last analyzed: Mar 16, 2026
Rapid Nutrition PLC researches, develops, and produces science-based health and wellness products. The company offers organic and natural health food supplements and oral anti-viral therapy products across the United Kingdom, Australia, Asia, the United States, and internationally.

Analyst Coverage for RPNRF: RPNRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RPNRF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the RPNRF film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 28/100 · F

RPNRF: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Bearish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Rapid Nutrition PLC (RPNRF) Healthcare & Pipeline Overview

CEOSimon Ledger
Employees12
HeadquartersMildenhall, GB
IPO Year2019

Rapid Nutrition PLC is a natural healthcare company focused on researching, developing, and producing science-based health and wellness products. With a global presence, the company offers organic and natural health food supplements and oral anti-viral therapies, operating in the competitive specialty and generic drug manufacturing sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for RPNRF?

As of Mar 16, 2026 — figures reflect the data available on that date.

Rapid Nutrition PLC operates in the growing natural healthcare market, offering potential for expansion through its established brands like SystemLS and Azurene. The company's gross margin of 71.7% indicates strong pricing power and efficient production. However, the company's negative profit margin of -265.6% raises concerns about its operational efficiency and cost management. The negative beta of -0.25 suggests the stock is less volatile than the market. Investors should closely monitor the company's ability to improve profitability and manage its expenses to capitalize on its revenue potential. Further analysis of the company's sales and marketing strategies is needed to determine its long-term growth prospects.

Based on FMP financials and quantitative analysis

RPNRF Key Highlights

Gross Margin of 71.7% indicates strong pricing power in the natural healthcare market.

  • Operates in multiple geographic regions including the United Kingdom, Australia, Asia, and the United States, providing diversification.
  • Offers products under established brands such as SystemLS, Leisa's Secret, and Azurene.
  • Focuses on science-based health and wellness products, appealing to health-conscious consumers.
  • Market capitalization of $4.75M indicates the company is a micro-cap stock with potential for high growth but also higher risk.

Who Are RPNRF's Competitors?

RPNRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AVTBF Avant Brands Inc. $0.43 +3.19% $6.63M 40
BBRRF Blueberries Medical Corp. $0.01 -24.29% $5.25M 59
CPIVF Captiva Verde Wellness Corp. $0.04 +65.13% $12.0M 48
INNPF INNOCAN PHARMA Corp $1.60 -8.05% $7.20M 61
GENH Generation Hemp, Inc. $0.22 +0.00% $25.3M 63
ETST Earth Science Tech, Inc. $0.11 +29.41% $31.7M 61
GBLP Global Pharmatech, Inc. $0.08 +0.00% $33.3M 62
GDNSF Goodness Growth Holdings, Inc. $0.45 +0.00% $61.1M 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are RPNRF's Key Strengths?

Established brands in the natural health supplement market.

  • Proprietary formulations and science-based approach.
  • International distribution network.
  • Gross margin of 71.7% indicates strong pricing power.

What Are RPNRF's Weaknesses?

Negative profit margin of -265.6% indicates significant operational inefficiencies.

  • Limited market capitalization of $4.75M.
  • Dependence on a small number of key products.
  • Small number of employees (12) may limit scalability.

What Could Drive RPNRF Stock Higher?

Potential expansion into new international markets, driving revenue growth.

  • Development and launch of new product lines targeting specific health needs.
  • Strategic partnerships to enhance distribution and market reach.
  • Increased online presence and e-commerce sales.
  • Clinical trials to validate product efficacy and build credibility.

What Are the Key Risks for RPNRF?

Financial-distress signal — its Altman Z-Score of 1.15 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-62.0%) — the business is not currently generating profit on shareholder capital.
  • Intense competition from larger pharmaceutical and nutraceutical companies.
  • Changes in regulations affecting the health supplement industry.
  • Economic downturns reducing consumer spending on non-essential health products.
  • Negative profit margin indicating operational inefficiencies.
  • Limited liquidity due to OTC Other tier status.

What Are the Growth Opportunities for RPNRF?

  • Expansion into new international markets: Rapid Nutrition can leverage its existing product portfolio to enter new geographic regions, particularly in emerging markets where demand for natural health products is growing. A targeted expansion strategy into regions with increasing disposable incomes and health awareness could significantly boost revenue. This expansion could be facilitated through strategic partnerships with local distributors and retailers. The global dietary supplements market is expected to continue growing, offering a favorable environment for international expansion.
  • Development of new product lines: Investing in research and development to create new and innovative health and wellness products can attract a wider customer base and increase revenue streams. Focusing on emerging health trends, such as personalized nutrition and preventative healthcare, can position Rapid Nutrition as a leader in the natural health market. New product lines could include specialized supplements, functional foods, and advanced therapies, catering to specific health needs and preferences.
  • Strategic partnerships and acquisitions: Collaborating with other companies in the healthcare and wellness industry can provide access to new technologies, distribution channels, and customer segments. Acquiring smaller, innovative companies can add valuable intellectual property and product lines to Rapid Nutrition's portfolio. Strategic partnerships can also facilitate market entry into new regions and enhance the company's competitive position.
  • Enhanced online presence and e-commerce strategy: Investing in a robust online platform and e-commerce strategy can improve customer engagement and drive sales. A user-friendly website, targeted online marketing campaigns, and social media engagement can increase brand awareness and attract new customers. Offering online consultations and personalized product recommendations can enhance the customer experience and build loyalty. The growing e-commerce market for health and wellness products provides a significant opportunity for Rapid Nutrition.
  • Focus on clinical trials and scientific validation: Conducting clinical trials to validate the efficacy of its products can enhance credibility and attract healthcare professionals and consumers. Publishing research findings in peer-reviewed journals can further strengthen the company's reputation and differentiate its products from competitors. Emphasizing scientific validation in marketing materials can build trust and drive sales, particularly among health-conscious consumers seeking evidence-based solutions.

What Are RPNRF's Competitive Advantages?

  • Brand recognition for SystemLS and Leisa's Secret in specific markets.
  • Proprietary formulations for certain health supplements.
  • Established distribution network in key geographic regions.
  • Focus on science-based and natural ingredients.

What Does RPNRF Do?

Founded in 2001 and based in London, United Kingdom, Rapid Nutrition PLC operates as a natural healthcare company, dedicated to the research, development, and production of science-based health and wellness products. The company's portfolio includes organic and natural scientific-based health food supplements marketed under the SystemLS and Leisa's Secret brands. Additionally, Rapid Nutrition offers oral anti-viral therapy products under the Azurene brand, designed to combat flu and the common cold. Rapid Nutrition distributes its products across the United Kingdom, Australia, Asia, the United States, and other international markets. The company aims to provide consumers with accessible and effective health solutions, leveraging scientific research to create innovative products. Rapid Nutrition operates in the competitive healthcare and wellness market, focusing on natural and organic supplements and therapies. The company's commitment to science-based formulations and global distribution network positions it to address the growing demand for natural healthcare solutions.

What Products and Services Does RPNRF Offer?

  • Researches and develops science-based health and wellness products.
  • Produces organic and natural health food supplements.
  • Offers oral anti-viral therapy products.
  • Markets products under the SystemLS and Leisa's Secret brands.
  • Provides anti-viral solutions under the Azurene brand.
  • Distributes products internationally across the United Kingdom, Australia, Asia, and the United States.

How Does RPNRF Make Money?

  • Develops and manufactures natural health products.
  • Markets and sells products through various distribution channels.
  • Generates revenue through the sale of health supplements and anti-viral therapies.

What Industry Does RPNRF Operate In?

Rapid Nutrition PLC operates within the specialty and generic drug manufacturing industry, a segment of the broader healthcare sector. This industry is characterized by intense competition, evolving regulatory landscapes, and increasing consumer demand for natural and organic health solutions. Rapid Nutrition competes with larger pharmaceutical companies and smaller specialized firms, requiring a focus on innovation and effective marketing to capture market share.

Who Are RPNRF's Key Customers?

  • Health-conscious consumers seeking natural and organic supplements.
  • Individuals looking for oral anti-viral therapies to combat flu and common cold.
  • Retailers and distributors in the health and wellness industry.
  • Customers in the United Kingdom, Australia, Asia, and the United States.
AI Confidence: 69% Updated: Mar 16, 2026

Company Profile

Rapid Nutrition PLC operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Mildenhall, GB. The company is led by CEO Simon Ledger. RPNRF has traded publicly since 2019.

F-Score 4/9

Financial Health

Rapid Nutrition PLC's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.15 places it in the distress zone, a signal of elevated financial risk.

ROE -62%

Key Financial Metrics

Return on equity for Rapid Nutrition PLC stands at -62.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -34.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -62.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 18.68 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -62.5%, the inverse of the P/E and a quick read on earnings relative to price.

RPNRF Valuation & Market Position

With a $4.75M market cap, Rapid Nutrition PLC sits in the micro-cap segment of the market.

FY2026 est

Forward Outlook

Wall Street analysts project Rapid Nutrition PLC revenue of about $3.3M for fiscal 2026, with EPS near $0.00.

RPNRF Financials

Fundamental Snapshot

Revenue Growth (FY)
-78.7%
Net Income Growth (FY)
-7.4%
Free Cash Flow Growth (FY)
-4.9%
Return on Equity (TTM)
-62.0%
Current Ratio
18.7
EV/EBITDA (TTM)
1.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Established brands in the natural health supplement market.
  • Proprietary formulations and science-based approach.
  • International distribution network.
  • Gross margin of 71.7% indicates strong pricing power.

Bear Case

  • Negative profit margin of -265.6% indicates significant operational inefficiencies.
  • Limited market capitalization of $4.75M.
  • Dependence on a small number of key products.
  • Small number of employees (12) may limit scalability.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

RPNRF Latest News

Leadership: Simon Ledger

Unknown

Information on Simon Ledger's background is not available. His experience and credentials are unknown. Further research would be required to determine his prior roles, education, and relevant expertise in the healthcare or pharmaceutical industry.

Track Record: Information on Simon Ledger's track record is not available. His achievements and strategic decisions at Rapid Nutrition PLC are unknown. Further research would be required to assess his performance and contributions to the company's growth and development.

RPNRF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Rapid Nutrition PLC may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Investing in OTC Other stocks carries a higher degree of risk due to the lack of regulatory oversight and transparency compared to stocks listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with distressed financials, early-stage ventures, or those that have been delisted from major exchanges.

  • OTC Tier: OTC Other
Liquidity: Liquidity for RPNRF on the OTC market is likely to be limited, given its OTC Other tier status and small market capitalization. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Low trading volumes can also increase price volatility, making it challenging to execute large trades without significantly impacting the stock price. Investors should be prepared for potential difficulties in entering and exiting positions in RPNRF due to these liquidity constraints.
OTC Risk Factors:
  • Limited financial disclosure increases information asymmetry and risk.
  • Low trading volume and liquidity can lead to price volatility.
  • OTC Other tier status indicates a higher risk of financial distress or regulatory issues.
  • Potential for wider bid-ask spreads, increasing transaction costs.
  • Lack of regulatory oversight compared to major exchanges.
Due Diligence Checklist:
  • Verify the company's financial statements and audit reports (if available).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Review the company's filings with the SEC or other regulatory agencies (if any).
  • Check for any legal or regulatory issues involving the company.
  • Evaluate the company's stock price history and trading volume.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • The company has been in operation since 2001.
  • The company has a global presence with distribution in multiple countries.
  • The company has established brands such as SystemLS and Azurene.
  • The company focuses on science-based health and wellness products.

Common Questions About RPNRF (Healthcare)

What happened to Rapid Nutrition PLC (RPNRF) stock?

Rapid Nutrition PLC (RPNRF) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.

Can I still buy RPNRF shares?

No. RPNRF stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for RPNRF elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before RPNRF stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Rapid Nutrition PLC. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Rapid Nutrition PLC do?

Rapid Nutrition PLC is a natural healthcare company that researches, develops, and produces science-based health and wellness products. It offers a range of organic and natural health food supplements under the SystemLS and Leisa's Secret brands, as well as oral anti-viral therapy products under the Azurene brand.

What do analysts say about RPNRF stock?

There is currently no available analyst coverage or consensus on Rapid Nutrition PLC (RPNRF) due to its OTC listing and limited market capitalization. Key valuation metrics such as price targets and ratings are not available. Investors should conduct their own due diligence and consider the company's financial performance, growth opportunities, and risk factors before making any investment decisions.

What are the main risks for RPNRF?

Rapid Nutrition PLC faces several risks, including intense competition from larger pharmaceutical and nutraceutical companies, which could limit its market share and pricing power. The company's negative profit margin of -265.6% indicates significant operational inefficiencies and financial challenges. Changes in regulations affecting the health supplement industry could also impact its ability to market and sell its products.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited and may not be fully up-to-date.
  • OTC market stocks carry higher risk than exchange-listed stocks.
  • AI analysis is pending and may provide further insights.
Data Sources

Popular Stocks

More Stocks We Cover